✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic WeeklyRoundupCannabisSector Why This MattersThis item covers developments relevant to cannabis medicine and clinical practice....
Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
✦ New CED Clinical Relevance #70 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Policy Watch | Federal Register PolicySafetyResearch Why This Matters I don't see a summary...
Schedule I Drug Classification: 3 Times Science Was Ignored
This meme isn’t exaggeration—it’s history repeating itself in policy. [caption id="attachment_15936" align="aligncenter" width="550"] They said “no medical value.” Science disagrees.[/caption] The Schedule I drug classification was meant to indicate substances with...